Introduction to Enclomiphene 12.5 mg in Research Contexts
Enclomiphene 12.5 mg is a chemically defined compound frequently utilized within research environments under Research Use Only (RUO) protocols. It is one of the isomers of clomiphene, distinguished by its unique molecular configuration. This article aims to provide a detailed overview of enclomiphene 12.5 mg, focusing on its chemical properties, laboratory applications, manufacturing considerations, and quality control measures, all within the framework of RUO compliance.
Chemical Properties and Molecular Structure
Enclomiphene is characterized by its selective isomeric form, differing structurally from its counterpart zuclomiphene. The molecular formula of enclomiphene is C26H28ClNO, with a molecular weight of approximately 405.96 g/mol. Its chemical structure features a triphenylethylene core, which is significant in its interaction with estrogen receptors in biochemical assays.
The compound’s stereochemistry is critical for its function in research applications, as the trans-isomeric form (enclomiphene) exhibits distinct binding affinities compared to the cis-isomer. This specificity is essential for studies requiring precise receptor modulation or molecular interaction analysis.
Research Applications and Laboratory Use
Within laboratory settings, enclomiphene 12.5 mg is employed primarily for investigative purposes, including receptor binding studies, molecular pathway analysis, and analytical method development. Its use is confined to controlled environments where researchers can explore its biochemical interactions without clinical or therapeutic implications.
Enclomiphene’s role in research extends to studies on estrogen receptor modulation, where it serves as a tool compound to elucidate receptor dynamics, ligand affinity, and downstream signaling pathways. These investigations contribute to the broader understanding of receptor pharmacology and molecular biology.
Manufacturing and Quality Control Considerations
The production of enclomiphene 12.5 mg for research purposes involves stringent manufacturing protocols to ensure purity, consistency, and batch-to-batch reproducibility. Analytical techniques such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS) are routinely employed to verify compound identity and purity.
Quality control processes include verification of chemical structure, assessment of impurities, and stability testing under various storage conditions. These measures are critical to maintain the integrity of research data and ensure reliable experimental outcomes.
Handling, Storage, and Safety in Research Environments
Proper handling and storage of enclomiphene 12.5 mg are essential to preserve its chemical stability and prevent degradation. The compound should be stored in a cool, dry place, protected from light and moisture, typically at temperatures recommended by the manufacturer or documented in the product specifications.
Laboratory personnel should adhere to standard safety protocols, including the use of personal protective equipment (PPE) and containment measures, to minimize exposure risks. Material Safety Data Sheets (MSDS) or Safety Data Sheets (SDS) provide detailed information on hazards, handling precautions, and emergency measures.
Regulatory and Compliance Aspects
Enclomiphene 12.5 mg is distributed under RUO classification, indicating its intended use exclusively for research and analytical purposes. It is not approved for diagnostic, therapeutic, or clinical applications. Compliance with regulatory guidelines ensures that the compound is utilized appropriately within research frameworks, maintaining ethical and legal standards.
Researchers and institutions should verify that their use of enclomiphene aligns with local regulations and institutional policies governing RUO materials. Documentation and traceability are important components of compliance management.
Analytical Techniques for Enclomiphene Characterization
Advanced analytical methodologies are integral to the characterization of enclomiphene 12.5 mg. Techniques such as:
- High-Performance Liquid Chromatography (HPLC): Used for purity assessment and quantification.
- Nuclear Magnetic Resonance (NMR) Spectroscopy: Provides detailed structural information.
- Mass Spectrometry (MS): Confirms molecular weight and identifies potential impurities.
These methods support quality assurance and facilitate research reproducibility by ensuring that the compound meets defined specifications.
Conclusion
Enclomiphene 12.5 mg is a well-defined chemical entity utilized within research environments under RUO guidelines. Its unique chemical properties and isomeric specificity make it valuable for molecular and receptor studies. Strict manufacturing and quality control protocols, combined with appropriate handling and regulatory compliance, ensure its suitability for laboratory applications.
For researchers seeking detailed product information or procurement options, additional resources are available at Axiocent’s product page.
Historical Development and Isomeric Significance of Enclomiphene
The discovery and characterization of enclomiphene as a distinct isomer emerged from extensive research into the stereochemistry of clomiphene citrate, a racemic mixture historically used in various biochemical investigations. Early analytical studies in the mid-20th century identified that clomiphene consisted of two geometric isomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). This differentiation was pivotal, as each isomer exhibited unique physicochemical properties and receptor interaction profiles.
Enclomiphene’s isolation and synthesis required advances in chromatographic separation techniques, including preparative high-performance liquid chromatography (HPLC) and crystallization methods. These developments allowed researchers to obtain enclomiphene in a purified form, facilitating more precise studies on its molecular behavior. The isomeric purity became a critical parameter, influencing the reproducibility and interpretability of experimental data.
From a chemical standpoint, the trans-configuration of enclomiphene contributes to its distinct three-dimensional conformation, affecting its binding affinity and selectivity in receptor assays. This stereochemical aspect underscores the importance of isomer-specific research reagents in elucidating receptor-ligand interactions and signaling mechanisms.
Comparative Analytical Profiles: Enclomiphene Versus Zuclomiphene
Analytical differentiation between enclomiphene and zuclomiphene is essential for quality control and research accuracy. Both isomers share the same molecular formula (C26H28ClNO) and molecular weight (~405.96 g/mol), but their stereochemical differences result in distinct chromatographic and spectroscopic signatures.
Chromatographically, enclomiphene and zuclomiphene exhibit different retention times under reversed-phase HPLC conditions, enabling their separation and quantification within mixtures. Method development often involves optimizing mobile phase composition, pH, and column selection to achieve baseline resolution. Such analytical precision is crucial for verifying isomeric purity in research-grade materials.
In nuclear magnetic resonance (NMR) spectroscopy, the isomers display characteristic chemical shift variations, particularly in the aromatic and olefinic proton regions. These spectral differences facilitate structural confirmation and assessment of stereochemical integrity. Additionally, coupling constants and NOE (Nuclear Overhauser Effect) experiments provide further stereochemical insights.
Mass spectrometry (MS) analysis confirms molecular weight but does not distinguish isomers directly; however, when coupled with chromatographic separation (LC-MS), it supports comprehensive profiling of enclomiphene-containing samples. Impurity profiling and degradation product identification also benefit from these combined techniques, ensuring compound stability and batch consistency.
Research Contexts and Emerging Analytical Methodologies
Beyond traditional analytical approaches, recent advancements have introduced novel methodologies for the characterization and study of enclomiphene 12.5 mg in research settings. Techniques such as chiral chromatography enable enantioselective separation, which, while not directly applicable to geometric isomers, contribute to the broader understanding of stereochemical purity in related compounds.
Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) have been employed to investigate the binding kinetics and thermodynamics of enclomiphene interactions with purified receptor proteins. These biophysical methods provide quantitative data on affinity and binding mechanisms, enhancing the molecular-level understanding of enclomiphene’s receptor engagement.
Computational chemistry and molecular modeling complement experimental data by simulating enclomiphene’s conformational dynamics and receptor docking. Such in silico analyses assist in predicting binding sites, energy profiles, and potential off-target interactions, informing experimental design and interpretation.
In quality assurance, stability-indicating methods incorporating forced degradation studies under varied environmental conditions (e.g., temperature, humidity, light exposure) have been developed. These studies identify degradation pathways and support the establishment of storage guidelines to maintain compound integrity over time.
Advanced Analytical Techniques for Enclomiphene 12.5 mg Characterization
Beyond conventional chromatographic and spectroscopic methods, recent research has incorporated cutting-edge analytical technologies to enhance the characterization of enclomiphene 12.5 mg. One such approach is chiral supercritical fluid chromatography (SFC), which offers rapid and high-resolution separation of stereoisomers and related impurities. Although enclomiphene is a geometric isomer rather than an enantiomer, SFC’s ability to finely discriminate subtle stereochemical differences has proven valuable in impurity profiling and purity verification within complex matrices.
Additionally, hyphenated techniques such as liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) have been optimized for the sensitive detection and quantification of enclomiphene and its potential degradation products. These methods utilize multiple reaction monitoring (MRM) modes to achieve high specificity and low limits of detection, facilitating comprehensive stability studies and batch consistency assessments.
Fourier-transform infrared (FTIR) spectroscopy, particularly when combined with attenuated total reflectance (ATR) accessories, has been employed to rapidly confirm functional group integrity and detect polymorphic variations in enclomiphene samples. This non-destructive technique supports routine quality control by providing fingerprint spectra that can be compared against reference standards.
Historical Context and Synthetic Advances in Enclomiphene Production
The synthetic development of enclomiphene 12.5 mg has evolved significantly since its initial isolation from racemic clomiphene mixtures. Early synthetic routes relied heavily on resolution techniques to separate the trans- and cis-isomers, often involving labor-intensive crystallization and preparative chromatography steps. These methods, while effective, presented scalability challenges for consistent production of research-grade enclomiphene.
Modern synthetic strategies have shifted towards asymmetric synthesis and stereoselective catalytic processes, enabling more efficient generation of the trans-isomer with enhanced purity. Advances in organometallic catalysis and chiral ligand design have contributed to improved yields and reduced byproduct formation. Such progress supports the availability of enclomiphene 12.5 mg with reproducible quality parameters essential for research applications.
Moreover, process analytical technology (PAT) integration during manufacturing facilitates real-time monitoring of reaction progress and stereochemical outcomes. Techniques such as in-line Raman spectroscopy and near-infrared (NIR) spectroscopy allow for immediate detection of isomer ratios and impurity levels, optimizing batch control and minimizing variability.
Comparative Stability and Degradation Pathways of Enclomiphene 12.5 mg
Understanding the chemical stability of enclomiphene 12.5 mg under various environmental conditions is critical for maintaining sample integrity in research settings. Forced degradation studies have elucidated primary degradation pathways, including photoisomerization, hydrolysis, and oxidative transformations. Exposure to ultraviolet (UV) light can induce isomeric interconversion or structural modifications, necessitating light-protective storage measures.
Hydrolytic degradation, particularly under acidic or basic conditions, may lead to cleavage of the ethylene linkage or substitution reactions on the aromatic rings. Oxidative stress, often simulated using hydrogen peroxide or other oxidants, can result in chlorinated aromatic ring modifications or formation of hydroxylated derivatives. These degradation products are typically characterized using LC-MS and NMR techniques to confirm structural changes.
Comparative studies indicate that enclomiphene exhibits greater chemical stability relative to its cis-isomer counterpart, zuclomiphene, under identical stress conditions. This differential stability profile informs handling protocols and shelf-life estimations. Stability-indicating analytical methods have been validated to detect both enclomiphene and its degradation products, ensuring comprehensive quality control throughout storage and experimental use.
n